Kyowa Kirin Co., Ltd.
4151Pharmaceuticals
¥2,401.50+0.33%As of Oct 29vs prior close
- Market cap
- $8B
- P/E (TTM)
- 15.4×
- P/E (FY1)
- 15.2×
- From 52W high
- −15.60%
- EPS (LTM)
- ¥155.37
- Revenue (LTM)
- ¥529.8B
- Net margin
- 15.35%
- Dividend yield
- 2.79%
Nomior Score
50
Steady ProfileSpeculativeBottom 49% of the scored universe
Growth41
Quality49
Value59
Momentum42
Resilience63
Growth
+7.64%revenue a year over 3 fiscal years
YE22 ¥398.4BLTM ¥529.8B
Connections
Revenue to profitYE25
13% of revenue became net profit, up 1 pt on a year.